https://investor.gm.com/news-releases/news-release-details/gm-continued-gain-us-market-share-and-extended-its-truck
NeuroBo To Present Latest Pre-Clinical Data On Cardiometabolic Assets, DA-1241 And DA-1726, Targeting MASH And Obesity, At Scientific Conferences In June
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced the acceptance of poster presentations for its